long intergenic non-protein coding RNA 2785Genealiases: []
Q-omics provides the consensus-scored LINC02785 profile across patient tissues and cancer cell-line models. LINC02785 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, LINC02785 is differentially expressed in 11, with the highest sampling consensus in THCA. Additionally, LINC02785 RNA expression shows 13,362 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight ACC, THCA, and LSCC as cancer lineages where LINC02785 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02785 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02785 survival associations across molecular data types. LINC02785 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02785 RNA expression–survival associations across cancer types. High LINC02785 expression shows unfavorable associations in ACC, LGG, UVM and KIRC, but favorable associations in HNSC and UCS. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for LINC02785 RNA expression.
This table summarizes LINC02785 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02785. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02785 shows lower tumor expression in LUAD, LUSC and KICH and higher tumor expression in THCA, KIRC and HNSC. The THCA box plot shows higher LINC02785 RNA expression in tumor versus normal tissue (log2 FC = +0.586, t-test p < 0.001).
This table shows molecular features associated with LINC02785 in patient tissues and cancer cell lines. In patient samples, LINC02785 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set.
